APA (7th ed.) Citation

Zhang, Q., Wei, A., Ma, H., Zhang, L., Lian, H., Wang, D., . . . Zhang, R. (2021). A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis. Haematologica (Roma), 106(7), 1892-1901. https://doi.org/10.3324/haematol.2020.253781

Chicago Style (17th ed.) Citation

Zhang, Qing, et al. "A Pilot Study of Ruxolitinib as a Front-line Therapy for 12 Children with Secondary Hemophagocytic Lymphohistiocytosis." Haematologica (Roma) 106, no. 7 (2021): 1892-1901. https://doi.org/10.3324/haematol.2020.253781.

MLA (9th ed.) Citation

Zhang, Qing, et al. "A Pilot Study of Ruxolitinib as a Front-line Therapy for 12 Children with Secondary Hemophagocytic Lymphohistiocytosis." Haematologica (Roma), vol. 106, no. 7, 2021, pp. 1892-1901, https://doi.org/10.3324/haematol.2020.253781.